Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Pretibial myxedema is a rare skin condition characterized by thickening and hardening of the skin, typically on the shins. While this condition is primarily diagnosed through clinical examination of the skin lesions, blood testing plays a crucial role in identifying and monitoring the underlying thyroid dysfunction that contributes to its development.
This test measures TSI antibodies that are characteristic of Graves' disease. Elevated TSI levels may contribute to pretibial myxedema by stimulating the accumulation of mucopolysaccharides and other substances in the skin, leading to the characteristic thickening and hardening. Monitoring TSI levels helps assess disease activity and guide treatment decisions.
Pretibial myxedema is strongly associated with Graves' disease, an autoimmune thyroid condition. The skin changes occur due to the accumulation of certain substances in the dermis, a process that can be triggered by specific thyroid antibodies. Blood testing is fundamental for assessing the underlying thyroid autoimmune activity that drives this skin manifestation.
Understanding the level of thyroid antibody activity through TSI testing provides valuable information about the autoimmune process underlying pretibial myxedema. This testing helps healthcare providers assess disease severity, monitor treatment response, and make informed decisions about managing both the thyroid condition and its skin manifestations.
The information here is for educational purposes only and is not a substitute for professional medical advice. Always consult with a healthcare provider for diagnosis and treatment.